- Home
- MFA vs CDNA Comparison
MFA vs CDNA Comparison
Compare MFA & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFA
- CDNA
- Stock Information
- Founded
- MFA 1997
- CDNA 1998
- Country
- MFA United States
- CDNA United States
- Employees
- MFA N/A
- CDNA N/A
- Industry
- MFA Real Estate Investment Trusts
- CDNA Medical Specialities
- Sector
- MFA Real Estate
- CDNA Health Care
- Exchange
- MFA Nasdaq
- CDNA Nasdaq
- Market Cap
- MFA 1.1B
- CDNA 1.1B
- IPO Year
- MFA N/A
- CDNA 2014
- Fundamental
- Price
- MFA $9.54
- CDNA $23.95
- Analyst Decision
- MFA Buy
- CDNA Buy
- Analyst Count
- MFA 4
- CDNA 8
- Target Price
- MFA $13.75
- CDNA $27.17
- AVG Volume (30 Days)
- MFA 1.3M
- CDNA 713.3K
- Earning Date
- MFA 02-20-2025
- CDNA 02-26-2025
- Dividend Yield
- MFA 14.66%
- CDNA N/A
- EPS Growth
- MFA N/A
- CDNA N/A
- EPS
- MFA 1.60
- CDNA N/A
- Revenue
- MFA $366,192,000.00
- CDNA $312,775,000.00
- Revenue This Year
- MFA N/A
- CDNA $19.85
- Revenue Next Year
- MFA $30.09
- CDNA $11.34
- P/E Ratio
- MFA $5.96
- CDNA N/A
- Revenue Growth
- MFA 164.50
- CDNA 5.26
- 52 Week Low
- MFA $9.51
- CDNA $7.42
- 52 Week High
- MFA $13.45
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- MFA 22.26
- CDNA 54.91
- Support Level
- MFA $9.88
- CDNA $22.00
- Resistance Level
- MFA $10.40
- CDNA $24.06
- Average True Range (ATR)
- MFA 0.23
- CDNA 1.08
- MACD
- MFA -0.04
- CDNA 0.33
- Stochastic Oscillator
- MFA 2.73
- CDNA 83.57
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.